COTY INC. 10-Q Summary: Quarter Ended March 31, 2025
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for COTY INC., a global beauty company, for the period ended March 31, 2025 (Fiscal Q3 2025). The company operates two primary reportable segments: Prestige (fragrances, cosmetics, skincare) and Consumer Beauty (mass market color cosmetics, fragrances, body care). The fiscal year ends June 30.
Key Financial Metrics
| Metric (in millions) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Revenues | $1,299.1 | $1,385.6 | $4,640.5 | $4,754.6 |
| Gross Profit | $832.4 | $897.8 | $3,041.2 | $3,063.8 |
| Operating (Loss) Income | $(280.4) | $77.8 | $225.6 | $512.0 |
| Net (Loss) Income Attributable to Coty | $(405.7) | $3.8 | $(299.1) | $186.3 |
| Operating Cash Flow (9M) | $409.4 | $438.1 | $409.4 | $438.1 |
| Total Debt (Gross) | $3,858.8 | $3,913.7 | $3,858.8 | $3,913.7 |
| Cash & Equivalents | $243.5 | $300.8 | $243.5 | $300.8 |
Material Changes vs. Prior Period
- Revenue Decline: Net revenues decreased 6% in Q3 and 2% for the nine months ended March 31, 2025. This was driven by negative foreign currency impacts (primarily Brazilian Real), declines in color cosmetics (U.S. and Europe), and the expiration of the Roberto Cavalli license.
- Significant Impairments: The company recorded $212.8 million in asset impairment charges in Q3 2025. This included write-downs for Max Factor ($84.0M), CoverGirl ($61.0M), Bourjois ($24.9M), and Philosophy ($42.9M) due to weakening demand in the color cosmetics market.
- Restructuring Costs: Restructuring costs surged to $76.6 million in Q3 2025 (vs. $0.9M prior year) due to a new "Fixed Cost Reduction Plan" announced in April 2025.
- KKW Termination: A loss of $71.0 million was recognized related to the termination of the KKW Collaboration Agreement and the sale of the KKW Holdings equity investment.
- Forward Repurchase Contracts: Net losses on forward repurchase contracts increased significantly to $78.5 million in Q3 2025 (vs. $17.2M prior year) due to declines in the company's stock price triggering hedge valuation adjustments.
Guidance, Outlook, and Risks
- Outlook: Management expects reported net revenue for fiscal 2025 to decline in the mid-single digits versus the prior year. Gross margin is anticipated to remain in the mid-sixties. The company targets advertising and consumer promotional spending in the high-twenties percentage of net revenues.
- Cost Reduction: The company is re-accelerating cost reduction efforts to deliver approximately $120.0 million in savings for fiscal 2025. The new Fixed Cost Reduction Plan is expected to cost approximately $80.0 million, split between fiscal 2026 and 2027.
- Tariff Risks: Recent U.S. tariff announcements are estimated to add $90.0 to $130.0 million in costs, primarily impacting prestige fragrances from Barcelona and components from China, with the majority expected in fiscal 2026.
- Legal Contingencies: Significant exposure remains regarding Brazilian tax assessments (approx. $350M+ in estimated liabilities) and ongoing talc-related litigation, though management believes current accruals are not material.
- Dividends: Common stock dividends remain suspended until the company approaches a Net Debt to Adjusted EBITDA target of 2x. Preferred stock dividends continue to accrue and are paid quarterly.
Investor Verification Checklist
- Impairment Sensitivity: Verify the assumptions used for the $212.8M impairment (discount rates and growth rates) as small changes could trigger further write-downs.
- Forward Repurchase Liability: Monitor the cash settlement liability on forward repurchase contracts, which increased to approx. $53.0M as of May 6, 2025, and could rise further if the stock price declines.
- Brazilian Tax Resolution: Track the status of the Goiás and Minas Gerais tax assessments, which require significant surety bonds and cash deposits.
- KKW Transition: Confirm the final financial impact of the KKW collaboration termination and the derecognition of related assets.
- Tariff Mitigation: Assess the company's ability to pass on the estimated $90M-$130M tariff costs through pricing or sourcing changes without further volume erosion.